Dean Robert Alan 4

What Happened

• Director Robert Alan Dean received a grant of 843 deferred share units (DSUs) on March 25, 2026. The grant is reported as an award/derivative (code A) with a per-unit value of $25.18, for a total reported value of $21,227. This was an award (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-03-25; Report filed: 2026-03-27.
• Units granted: 843 DSUs; Reported per‑unit value: $25.18; Total value: $21,227 (value based on Nasdaq close 2026-03-24).
• Shares owned after transaction: Not disclosed in the filing excerpt provided.
• Footnote highlights:
  • The DSU entitles the holder to one common share (or, at the holder’s election and subject to plan admin approval, cash equal to its value) at settlement. The Reporting Person chose DSUs instead of a cash retainer for Q1 2026.
  • The DSUs are fully vested as of the grant date and will be settled following the reporting person’s separation from service.
• Transaction type: Derivative award (not a purchase or sale), coded A.

Context

• Deferred share units are a form of compensation that convert to company shares (or cash) later and do not represent an immediate open‑market investment by the insider. Because DSUs are vested and payable upon separation, they are typically a retention/compensation mechanism rather than a signal of a near‑term trading intent. The filing appears timely (reported two days after the grant).